Results 61 to 70 of about 2,067 (154)

Functionalizing Injectable Hydrogels with Cobalt‐Based Metallacarboranes for Targeted Delivery in Triple‐Negative Breast Cancer

open access: yesChemBioChem, Volume 26, Issue 21, November 8, 2025.
This study reports a biocompatible HA–lysine hydrogel loaded with cobalt metallacarborane (CoSAN) for targeted release into triple‐negative breast cancer cells. The system maintains CoSAN cytotoxicity, as confirmed by cell assays and imaging, representing an attractive approach toward a localised TNBC treatment.
Neville Murphy   +11 more
wiley   +1 more source

Investigations into the characterization, degradation, and applications of biodegradable polymers by mass spectrometry

open access: yesMass Spectrometry Reviews, Volume 44, Issue 6, Page 947-988, November/December 2025.
Abstract Biodegradable polymers have been getting more and more attention because of their contribution to the plastic pollution environmental issues and to move towards a circular economy. Nevertheless, biodegradable materials still exhibit various disadvantages restraining a widespread use in the market.
Paola Rizzarelli   +2 more
wiley   +1 more source

Maxwell Spectrum as a Parameter to Verify the Dose in Brain Cancer (Glioblastoma) by Boron Neutron Capture Therapy (BNCT) using Monte Carlo Method

open access: yesBrazilian Journal of Radiation Sciences
To evaluate the efficiency of neutron capture therapy (BNCT) treatment in glioblastoma multiforme, it is necessary to evaluate the impact of the neutron beam on the tumor cell and find better results so that BNCT treatment is viable.
Otto Haubrich   +2 more
doaj   +1 more source

Boronated Compounds for Imaging Guided BNCT Applications

open access: yesAnti-Cancer Agents in Medicinal Chemistry, 2012
Boron neutron capture therapy (BNCT) is based on the capture of thermal neutrons by boron 10 ((10)B) nuclei that have been selectively delivered to tumor cells. The amount of 10-30 μg of boron for g of tumor mass is needed to attain an acceptable therapeutic advantage.
GENINATTI CRICH, Simonetta   +5 more
openaire   +3 more sources

Recent research progress of BNCT treatment planning system

open access: yesNuclear Engineering and Technology
Boron neutron capture therapy (BNCT) is a type of radiation therapy that can selectively kill tumor cells. It is necessary to design a suitable treatment plan and assess its efficacy based on the actual situation of the patient before BNCT treatment. The
Zhaotong Wang   +7 more
doaj   +1 more source

Development of an integrated Monte Carlo model for glioblastoma multiforme treated with boron neutron capture therapy

open access: yesScientific Reports, 2017
Glioblastomas (GBM) are notorious for their high fatality rate. Boron Neutron Capture Therapy (BNCT) being a biochemically targeted type of radiotherapy is a potent modality for GBM.
Leyla Moghaddasi, Eva Bezak
doaj   +1 more source

ABSTRACTS

open access: yes
Precision Radiation Oncology, EarlyView.
wiley   +1 more source

Preliminary outcomes of boron neutron capture therapy for head and neck cancers as a treatment covered by public health insurance system in Japan: Real‐world experiences over a 2‐year period

open access: yesCancer Medicine
Purpose Since June 2020, boron neutron capture therapy (BNCT) has been a health care service covered by health insurance in Japan to treat locally advanced or recurrent unresectable head and neck cancers.
Satoshi Takeno   +9 more
doaj   +1 more source

Development of a New Image Reconstruction Method Using Bayesian Estimation with Limited View-Angle Projection Data for BNCT-SPECT

open access: yesApplied Sciences
Boron Neutron Capture Therapy (BNCT) is an emerging radiation treatment for cancer, and its challenges are being explored. Systems capable of capturing real-time observations of this treatment’s effectiveness, particularly BNCT-SPECT methods that measure
Fan Lu   +5 more
doaj   +1 more source

Comparison of lifetime attributable risk of post-irradiation secondary cancer of boron neutron capture therapy, proton beam therapy, and X-ray therapy for pediatric and adolescent and young adult patients

open access: yesClinical and Translational Radiation Oncology
Background and purpose: This study aimed to compare the post-irradiation secondary cancer rates of boron neutron capture therapy (BNCT), proton beam therapy (PBT), and X-ray therapy (XT) in pediatric and Adolescent and Young Adult (AYA) patients with ...
Shunsuke Suzuki   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy